Targeted Cancer Immune Therapy - Lustgarten, Joseph; Cui, Yan.; Li, Shulin; SpringerLink (Online service) (New York, NY : Springer New York : Imprint: Springer, 2009)
Cytokine Immune Therapy -- Role of IL12 Family in Regulation of Antitumor Immune Response -- IL-18 in Regulation of Antitumor Immune Response and Clinical Application -- Interleukin-21 and Cancer Therapy -- IL-24 in Regulation of Antitumor Immune Response and in Signaling -- IL-28 and IL-29 in Regulation of Antitumor Immune Response and Induction of Tumor Regression -- Passive and Active Tumor Homing Cytokine Therapy -- Cell-based Immune Therapy -- New Strategies to Improve Tumor Cell Vaccine Therapy -- Modification of Dendritic Cells to Enhance Cancer Vaccine Potency -- Dendritic Cell Vaccines for Immunotherapy of Cancer: Challenges in Clinical Trials -- A "Toll Bridge" for Tumor-Specific T Cells -- Engineering Adult Stem Cells for Cancer Immunotherapy -- Animal Models for Evaluating Immune Responses of Human Effector Cells In Vivo -- Targeted Immune Therapy -- CD40 Stimulation and Antitumor Effects -- Immunocytokines: A Novel Approach to Cancer Immune Therapy -- Immune Escape: Role of Indoleamine 2,3-Dioxygenase in Tumor Tolerance -- Adoptive Transfer of T-Bodies: Toward an Effective Cancer Immunotherapy -- Targeting Toll-Like Receptor for the Induction of Immune and Antitumor Responses -- Manipulating TNF Receptors to Enhance Tumor Immunity for the Treatment of Cancer.
Keywords: Cancer research; Pharmacology; Cancer Research; Pharmacology/Toxicology.